[Antiplatelet drugs (author's transl)].
Acetyl salicylic acid, sulfinpyrazone, dipyridamole, hydroxychloroquine, ticlopidine, clofibrate, nicergoline are the most used antiplatelet drugs. A. S. A. and sulfinpyrazone have been tested in several large scale clinical trials. A. S. A. seems beneficial in the prevention of cerebral ischemia for patients, specially men who have previously had a transient cerebral ischemic attack. Sulfinpyrazone appears to be effective in reducing cardiac deaths during the first year after myocardial infarction.
D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects*; D002994:Clofibrate / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000494:pharmacology; D002546:Ischemic Attack, Transient / Q000517:prevention & control; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy; D009530:Nicergoline / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects*; D013442:Sulfinpyrazone / Q000494:pharmacology / Q000627:therapeutic use; D013927:Thrombosis / Q000517:prevention & control*
D006886:Hydroxychloroquine; D004176:Dipyridamole; D002994:Clofibrate; D009530:Nicergoline; D001241:Aspirin; D013442:Sulfinpyrazone
Les inhibiteurs des fonctions plaquettaires ou anti-agrégants.